Provider
P31-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Thrombopoietin Receptor Agents
Program effective Date: Jun 05, 2017
Program effective Date: Jun 05, 2017
Program effective Date: Jun 05, 2017
Program effective Date: Jun 05, 2017
Program effective Date: May 31, 2017
Program effective Date: May 30, 2017
Program effective Date: May 25, 2017
Program effective Date: May 25, 2017
Program effective Date: May 25, 2017
Program effective Date: May 25, 2017
Program effective Date: May 23, 2017